ABOS
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. (ABOS) has 13 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 17, 2026.
The most active filer is Director Porter Derrell with 3 filings. Insiders have net sold $125K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Daniel J. O'Connell
- Employees:61
- HQ:Newton, VA, US
- IPO:2021-07-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$125K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$164.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Porter DerrellFirst filing | Director | Sale | 6,460 | $15K | Jun 17 | SEC ↗ |
Porter DerrellFirst filing | Director | Sale | 12,800 | $30K | Jun 17 | SEC ↗ |
Porter DerrellFirst filing | Director | Sale | 13,040 | $30K | Jun 17 | SEC ↗ |
Fountain Nathan BFirst filing | Director | Sale | 6,400 | $14K | Jun 10 | SEC ↗ |
| Chief Legal Officer & Corp Sec | Sale | 2,090 | $7K | Mar 10 | SEC ↗ | |
Meisner Derek MFirst filing | Chief Legal Officer & Corp Sec | Sale | 9,406 | $28K | Mar 3 | SEC ↗ |
Related companies
Acumen Pharmaceuticals, Inc. is in the Healthcare sector.